Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen, Elan Win U.S. FDA Approval of Tysabri Label Change to Target Use
Biogen, Elan Win U.S. FDA Approval of Tysabri Label Change to Target Use
Biogen, Elan Win U.S. FDA Approval of Tysabri Label Change to Target Use
Submitted by
admin
on January 21, 2012 - 1:04pm
Source:
Bloomberg
News Tags:
Biogen Idec
Elan
Tysabri
multiple sclerosis
Headline:
Biogen, Elan Win U.S. FDA Approval of Tysabri Label Change to Target Use
Do Not Allow Advertisers to Use My Personal information
